Clinical epidemiology and viral genomics insights from a Chikungunya fever outbreak in South China, 2025
Frontiers in Cellular and Infection Microbiology · 23.01.2026 · 16
DOI: 10.3389/fcimb.2026.1762631 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 23.01.2026. Verfasst von Fangfang He und 15 weiteren Autor:innen. Beteiligte Einrichtung: Infection Control Department, Lecong Hospital of Shunde, Foshan, China. Hauptthemen laut MEDLINE: Disease Outbreaks, Chikungunya Fever, Chikungunya virus, Genome, Viral. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Chikungunya fever (CHIKF) is a mosquito-borne viral disease characterized by fever, rash, and severe joint pain. However, these classical descriptions are based overwhelmingly on the Indian Ocean and Caribbean lineages. With the recent introduction and spread of the Middle Africa lineage (MAL) into Asia, understanding its clinical presentation in new populations, such as Chinese, has become a public health priority. Whether the recently introduced MAL causes comparably severe disease in China remains unknown.
Methods
We enrolled 415 laboratory-confirmed cases of Chikungunya virus (CHIKV) infection during an outbreak in Foshan, China. Clinical manifestations, laboratory parameters, and whole-genome sequencing data were integrated to quantify the symptom burden from three different perspectives using multivariate logistic regression, and to trace the viral source via maximum-likelihood phylogenetic analysis.
Results
Compared with the classical phenotype, the MAL outbreak in China was appreciably milder. The most common clinical manifestations were arthralgia (83.61%), fever (74.46%), and rash (61.93%). Multivariate logistic regression showed that older age (OR = 0.979, P = 0.029) and male sex (OR = 0.528, P = 0.038) were negatively correlated with the occurrence of higher symptom burden, while prolonged fever (OR = 8.156, P < 0.001) was a significant risk factor. Reduced estimated glomerular filtration rate and thrombocytopenia were associated with longer disease duration. Phylogenetic analysis revealed that the outbreak-associated CHIKV strains belonged to MAL and harbored the E1-A226V and E2-I211T mutations.
Conclusion
These findings provide an evidence base for clinical management and prognostic assessment during CHIKF outbreaks and underscore the importance of monitoring laboratory parameters alongside molecular surveillance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Infection Control Department, Lecong Hospital of Shunde, Foshan, China.
- Southern China Center for Disease Control and Prevention, Guangzhou, China.
- Biosafety Department, School of Basic Medical Sciences, Army Medical University, Chongqing, China.
- The Chinese PLA Center for Disease Control and Prevention, Beijing, China.
Zitieren
APA
He, F., Liang, Y., Gong, Y., Li, P., Yu, J., Wei, C., He, J., Li, F., Yu, R., Yang, W., Yi, C., Lin, A., Yu, W., Li, P., Li, J., & Yan, H. (2026). Clinical epidemiology and viral genomics insights from a Chikungunya fever outbreak in South China, 2025. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1762631
Vancouver
He F, Liang Y, Gong Y, Li P, Yu J, Wei C, et al. Clinical epidemiology and viral genomics insights from a Chikungunya fever outbreak in South China, 2025. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1762631
BibTeX
@article{He2026,
author = {He, Fangfang and Liang, Yufeng and Gong, Yuanxin and Li, Peihan and Yu, Jiayin and Wei, Chuhong and He, Jian and Li, Fenxiang and Yu, Ruolan and Yang, Wei and Yi, Cuixiang and Lin, Aiyang and Yu, Wenting and Li, Peng and Li, Jintao and Yan, Huacheng},
title = {Clinical epidemiology and viral genomics insights from a Chikungunya fever outbreak in South China, 2025},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1762631}
}
EUVIMED